Register for press alerts

whenever there’s news, you’ll know

Sign-up to receive alli press email alerts and you’ll receive all the latest news on alli. Whatever's happening with alli and the alli weight loss programme, you can make sure you're among the first to know all the facts.

Take a minute to complete the form and we’ll keep you informed.

Fields marked with an asterisk (*) are required.

First Name *
Surname *
Email *
Confirm Email *
Media Industry *
Journalist Type *
By ticking this box, you confirm that you are 18 or over, a journalist and that you have read the Terms & Conditions and Privacy & Cookies Policy. Further, you are granting GlaxoSmithKline Consumer Healthcare permission to send you communications on alli. Our goal is to provide value to you with timely health information, valuable promotional offers, relevant product news or to request your feedback. We respect your privacy and you will always be given the opportunity to stop such communication in accordance with our Privacy & Cookies Policy . *

change region: United Kingdom

alli 60 mg capsules are a weight loss aid containing orlistat. For overweight adults with a BMI of 28 or over. Follow a reduced calorie, lower-fat diet. Always read the label.

alli, Shuttle and the Shuttle Carry Case are trademarks of the GlaxoSmithKline group of companies.